Skip to content
Recall Observatory FDA recall evidence

Drug product

Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV

D-0492-2017

January 19, 2017

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 76357
Status
Terminated
Classification
Class II
Quantity
37,445 bottles
Official record key
drug-enforcement:D-0492-2017

Official wording

Reason: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle

Code information: a) 3078937 and 3078938 (NDC 0378-3545-93), exp August 2019 b) 3078937 (NDC 0378-3545-01), exp August 2019 c) 3078936 (0378-3545-05), exp August 2019

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets